Production (Stage)
Deltex Medical Group plc
DTXMF
$0.0952
$0.09223,073.33%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 1.58% | -136.35% | 0.52% | 25.18% | 1.89% |
| Total Depreciation and Amortization | -1.86% | -12.60% | -0.40% | -44.74% | -1.97% |
| Total Amortization of Deferred Charges | -1.67% | 1.89% | -0.56% | 2,705.26% | 0.00% |
| Total Other Non-Cash Items | -1.59% | 1,291.03% | -0.46% | -61.77% | -1.89% |
| Change in Net Operating Assets | -1.64% | 302.54% | 0.58% | 79.51% | 1.92% |
| Cash from Operations | 1.34% | 89.10% | 0.51% | 50.11% | 1.88% |
| Capital Expenditure | 1.69% | -- | -- | -- | 0.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.35% | -753.85% | 0.00% | 101.68% | 1.90% |
| Cash from Investing | 1.40% | -1,200.00% | 0.00% | 101.64% | 1.85% |
| Total Debt Issued | 0.00% | -48.61% | 0.00% | -- | -- |
| Total Debt Repaid | 0.00% | 0.00% | 0.00% | 70.41% | 0.00% |
| Issuance of Common Stock | -- | -- | -- | -- | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 0.00% |
| Cash from Financing | -1.92% | -80.81% | -0.73% | -97.25% | -1.89% |
| Foreign Exchange rate Adjustments | 1.28% | -326.09% | -1.43% | -43.55% | -2.36% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.65% | 77.12% | 0.50% | -164.70% | -1.90% |